Jing LI, Ya LUO, Shengwei ZHANG, et al. Mechanism of zingerone alleviating colitis induced by dextran sodium sulfate in mice[J]. Journal of Army Medical University, 2023, 45(6): 519-529.
DOI:
Jing LI, Ya LUO, Shengwei ZHANG, et al. Mechanism of zingerone alleviating colitis induced by dextran sodium sulfate in mice[J]. Journal of Army Medical University, 2023, 45(6): 519-529. DOI: 10.16016/j.2097-0927.202212057.
Mechanism of zingerone alleviating colitis induced by dextran sodium sulfate in mice
To investigate the efficacy of zingerone (Zin) on dextran sodium sulfate (DSS)-induced colitis in mice and its potential immunomodulatory mechanism.
Methods
2
SPF C57BL/6 male mice aged 6 to 8 weeks were divided into control group (Water)
model group (DSS)
and Zin intervention group (DSS+Zin)
with 5 mice in each group. Acute ulcerative colitis model was constructed using DSS solution
and the changes in body weight
disease activity index (DAI)
colon length
and histopathological scores were compared among the groups. RT-qPCR and corresponding reagents and kits were employed to detect the mRNA and protein expression of inflammatory cytokines in the colonic tissue
respectively. The effects of Zin on T cell subsets and on the expression of transcription factor RORγt were determined by flow cytometry
in vitro
and
in vivo
. Moreover
the transcriptional activity of RORγt and activity of Rorc promoter were examined using dual-luciferase reporter system.
Results
2
As compared with the control group
the mice in the DSS group showed shorter colon length
higher scores of DAI and histopathological index (
P
<
0.05)
with increased mRNA levels of
IL
-17
A
IL
-21
IL
-22
IL
-6
IL-1
β
and
IFN-γ
(
P
<
0.05)
while decreased mRNA level
of
TGF-β
(
P
<
0.05). The protein levels of IL-17A
IL-17F
IL-22
and IFN-γ were also upregulated in the DSS group (
P
<
0.05). However
Zin treatment significantly relieved the above clinical symptoms and reversed the expression of above inflammatory factors (
P
<
0.05). Flow cytometry indicated that Zin inhibited the differentiation of Th17 cells and the expression of RORγt
and promoted the differentiation of Treg cells both
in vitro
and
in vivo
(
P
<
0.05)
but the differentiation of Th1 subset was not affected. The dual-luciferase reporter assay demonstrated that the transcriptional activity of RORγt and Rorc promoter activity were remarkably suppressed after Zin treatment (
P
<
0.05).
Conclusion
2
Zin alleviates DSS-induced colitis in mice by regulating the balance of Th17/Treg cells and inhibiting RORγt expression.
关键词
Keywords
references
KAPLNA G G, NG S C. Understanding and preventing the global increase of inflammatory bowel disease[J]. Gastroenterology, 2017, 152(2): 313-321. e2. DOI: 10.1053/j.gastro.2016.10.020.
XAVIER R J, PODOLSKY D K. Unravelling the pathogenesis of inflammatory boweldisease[J]. Nature, 2007, 448(7152): 427-434. DOI: 10.1038/nature06005.
DE SOUZA H S, FIOCCHI C. Immunopathogenesis of IBD: current state of the art[J]. Nat Rev Gastroenterol Hepatol, 2016, 13(1): 13-27. DOI: 10.1038/nrgastro.2015.186.
PRINZ I, KLEMM U, KAUFMANN S H, et al . Exacerbated colitis associated with elevated levels of activated CD4+T cells in TCR alpha chain transgenic mice[J ] . Gastroenterology, 2004, 126(1): 170-181. DOI: 10.1053/j.gastro.2003.10.062.
DAVIDSON N J, LEACH M W, FORT M M, et al . T helper cell 1-type CD4+ T cells, but notB cells, mediate colitis in interleukin 10-deficient mice[J ] . J Exp Med, 1996, 184(1): 241-251. DOI: 10.1084/jem.184.1.241.
XU Y, HE S Q, LI H L. Research progress of intestinal mucosal immune cells in ulcerative colitis[J].J Gannan Med Univ,2013, 33(1): 156-160. DOI: 10.3969/j.issn.1001-5779.2013.01.076.
UENO A, JEFFERY L, KOBAYASHI T, et al . Th17 plasticity and its relevance to inflammatory bowel disease[J ] . J Autoimmun, 2018, 87: 38-49. DOI: 10.1016/j.jaut.2017.12.004.
YAN J B, LUO M M, CHEN Z Y, et al . The function and role of the Th17/treg cell balance in inflammatory bowel disease[J ] . J Immunol Res, 2020, 2020: 8813558. DOI: 10.1155/2020/8813558.
NEURATH M F. Current and emerging therapeutic targets for IBD[J]. Nat Rev Gastroenterol Hepatol, 2017, 14(5): 269-278. DOI: 10.1038/nrgastro.2016.208.
AHMAD B, REHMAN M U, AMIN I, et al . A review on pharmacological properties of zingerone[4-(4-hydroxy-3-methoxyphenyl)-2-butanone ] [J ] . Sci World J, 2015, 2015: 816364. DOI: 10.1155/2015/816364.
BALIGA M S, HANIADKA R, PEREIRA M M, et al . Update on the chemopreventive effects of ginger and its phytochemicals[J ] . Crit Rev Food Sci Nutr, 2011, 51(6): 499-523. DOI: 10.1080/10408391003698669.
KIYAMA R. Nutritional implications of ginger: chemistry, biological activities and signaling pathways[J]. J Nutr Biochem, 2020, 86: 108486. DOI: 10.1016/j.jnutbio.2020.108486.
HSIANG C Y, LO H Y, HUANG H C, et al . Ginger extract and zingerone ameliorated trinitrobenzene sulphonic acid-induced colitis in mice via modulation of nuclear factor-κB activity and interleukin-1β signalling pathway[J ] . Food Chem, 2013, 136(1): 170-177. DOI: 10.1016/j.foodchem.2012.07.124.
KAZEMI M, JAFARZADEH A, NEMATI M, et al . Zingerone improves the immune responses in an animal model of breast cancer[J ] . J Complement Integr Med, 2021, 18(2): 303-310. DOI: 10.1515/jcim-2019-0135.
KIM J J, SHAJIB M S, MANOCHA M M, et al . Investigating intestinal inflammation in DSS-induced model of IBD[J ] . J Vis Exp, 2012(60): 3678. DOI: 10.3791/3678.
FLAHERTY S, Reynolds J M. Mouse naïve CD4+ T cell isolation and in vitro differentiation into T cell subsets[J ] . J Vis Exp, 2015 Apr 16, (98): 52739. DOI: 10.3791/52739.
ZHAO Y, LUAN H, JIANG H, et al . Gegen qinlian decoction relieved DSS-induced ulcerative colitis in mice by modulating Th17/Treg cell homeostasis via suppressing IL-6/JAK2/STAT3 signaling[J ] . Phytomedicine, 2021, 84: 153519. DOI: 10.1016/j.phymed.2021.153519..
EICHELE D D, KHARBANDA K K. Dextran sodium sulfate colitis murine model: an indispensable tool for advancing our understanding of inflammatory bowel diseases pathogenesis[J]. World J Gastroenterol, 2017, 23(33): 6016-6029. DOI: 10.3748/wjg.v23.i33.6016.
ZHOU L, CHONG M M, LITTMAN D R. Plasticity of CD4+ T cell lineage differentiation[J]. Immunity, 2009, 30(5): 646-655. DOI: 10.1016/j.immuni.2009.05.001.
TUMES D J, PAPADOPOULOS M, ENDO Y, et al . Epigenetic regulation of T-helper cell differentiation, memory, and plasticity in allergic asthma[J ] . Immunol Rev, 2017, 278(1): 8-19. DOI: 10.1111/imr.12560.
XU M, DUANX Y, CHEN Q Y, et al . Effect of compound sophorae decoction on dextran sodium sulfate (DSS)-induced colitis in mice by regulating Th17/Treg cell balance[J ] . Biomed Pharmacother, 2019, 109: 2396-2408. DOI: 10.1016/j.biopha.2018.11.087.
SCHMITT H, ULMSCHNEIDER J, BILLMEIER U, et al . The TLR9 agonist cobitolimod induces IL10-producing wound healing macrophages and regulatory T cells in ulcerative colitis[J ] . J Crohns Colitis, 2020, 14(4): 508-524. DOI: 10.1093/ecco-jcc/jjz170.
CUI H, CAI Y, WANG L, et al . Berberine regulates treg/Th17 balance to treat ulcerative colitis through modulating the gut microbiota in the colon[J ] . Front Pharmacol, 2018, 9: 571. DOI: 10.3389/fphar.2018.00571.
LIU Y J, TANG B, WANG F C, et al . Parthenolide ameliorates colon inflammation through regulating Treg/Th17 balance in a gut microbiota-dependent manner[J ] . Theranostics, 2020, 10(12): 5225-5241. DOI: 10.7150/thno.43716.
WEN S, HE L, ZHONG Z, et al . Stigmasterol restores the balance of treg/Th17 cells by activating the butyrate-PPARγ axis in colitis[J ] . Front Immunol, 2021, 12: 741934. DOI: 10.3389/fimmu.2021.741934.
CHANG Y, ZHAI L, PENG J, et al . Phytochemicals as regulators of Th17/Treg balance in inflammatory bowel diseases[J ] . Biomed Pharmacother, 2021, 141: 111931. DOI: 10.1016/j.biopha.2021.111931.
FITZPATRICK L R. Inhibition of IL-17 as a pharmac-ological approach for IBD[J]. Int Rev Immunol, 2013, 32(5/6): 544-555. DOI: 10.3109/08830185.2013.821118.
KOMIYAMA Y, NAKAE S, MATSUKI T, et al . IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis[J ] . J Immunol, 2006, 177(1): 566-573. DOI: 10.4049/jimmunol.177.1.566.
WAISMAN A, HAUPTMANN J, REGEN T. The role of IL-17 in CNS diseases[J]. Acta Neuropathol, 2015, 129(5): 625-637. DOI: 10.1007/s00401-015-1402-7.
IVANOV I I, MCKENZIE B S, ZHOU L, et al . The orphan n uclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells[J ] . Cell, 2006, 126(6): 1121-1133. DOI: 10.1016/j.cell.2006.07.035.
HUH J R, LEUNG M W, HUANG P, et al . Digoxin and its derivatives suppress TH17 cell differentiation by antagonizing RORγt activity[J ] . Nature, 2011, 472(7344): 486-490. DOI: 10.1038/nature09978.
SOLT L A, KUMAR N, NUHANT P, et al . Suppression of TH17 differentiation and autoimmunity by a synthetic ROR ligand[J ] . Nature, 2011, 472(7344): 491-494. DOI: 10.1038/nature10075.
XUT, WANG X, ZHONG B, et al . Ursolic acid suppresses interleukin-17 (IL-17) production by selectively antagonizing the function of RORgamma T protein[J ] . J Biol Chem, 2011, 286(26): 22707-22710. DOI: 10.1074/jbc.c111.250407.
HANG S, PAIK D, YAO L, et al . Bile acid metabolites control T H 17 and T reg cell differentiation[J ] . Nature, 2019, 576(7785): 143-148. DOI: 10.1038/s41586-019-1785-z..
ICHIYAMA K, SEKIYA T, INOUE N, et al . Transcription factor Smad-independent T helper 17 cell induction by transforming-growth factor-β is mediated by suppression of eomesodermin[J ] . Immunity, 2011, 34(5): 741-754. DOI: 10.1016/j.immuni.2011.02.021.